Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Surgery
Volume 2015, Article ID 273641, 5 pages
http://dx.doi.org/10.1155/2015/273641
Case Report

Intraoperative Conversion to ALPPS in a Case of Intrahepatic Cholangiocarcinoma

1Regenerative Medicine & Experimental Surgery (ReMediES), Department of General, Visceral and Transplant Surgery, Hannover Medical School, 30625 Hannover, Germany
2Department of Diagnostic and Interventional Radiology, Hannover Medical School, 30625 Hannover, Germany

Received 15 August 2015; Revised 19 October 2015; Accepted 27 October 2015

Academic Editor: Gregorio Santori

Copyright © 2015 F. Oldhafer et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Khan, M. B. Toledano, and S. D. Taylor-Robinson, “Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma,” HPB, vol. 10, no. 2, pp. 77–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. B. Blechacz and G. J. Gores, “Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment,” Hepatology, vol. 48, no. 1, pp. 308–321, 2008. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Razumilava and G. J. Gores, “Classification, diagnosis, and management of cholangiocarcinoma,” Clinical Gastroenterology and Hepatology, vol. 11, no. 1, pp. 13–21.e1, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. H. H. Lutz, C. Trautwein, and J. J. W. Tischendorf, “Primary sclerosing cholangitis: diagnosis and treatment,” Deutsches Arzteblatt International, vol. 110, no. 51-52, pp. 867–874, 2013. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. H. Shaib, H. B. El-Serag, J. A. Davila, R. Morgan, and K. A. McGlynn, “Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study,” Gastroenterology, vol. 128, no. 3, pp. 620–626, 2005. View at Publisher · View at Google Scholar · View at Scopus
  6. H. Bektas, C. Yeyrek, M. Kleine et al., “Surgical treatment for intrahepatic cholangiocarcinoma in Europe: a single center experience,” Journal of Hepato-Biliary-Pancreatic Sciences, vol. 22, no. 2, pp. 131–137, 2015. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Guglielmi, A. Ruzzenente, T. Campagnaro et al., “Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection,” World Journal of Surgery, vol. 33, no. 6, pp. 1247–1254, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. E. de Santibañes and P.-A. Clavien, “Playing Play-Doh to prevent postoperative liver failure: the ‘ALPPS’ approach,” Annals of Surgery, vol. 255, no. 3, pp. 415–417, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Hernandez-Alejandro, K. A. Bertens, K. Pineda-Solis, and K. P. Croome, “Can we improve the morbidity and mortality associated with the associating liver partition with portal vein ligation for staged hepatectomy (ALPPS) procedure in the management of colorectal liver metastases?” Surgery, vol. 157, no. 2, pp. 194–201, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Stockmann, J. F. Lock, M. Malinowski, S. M. Niehues, D. Seehofer, and P. Neuhaus, “The LiMAx test: a new liver function test for predicting postoperative outcome in liver surgery,” HPB, vol. 12, no. 2, pp. 139–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. S. Truant, O. Scatton, S. Dokmak et al., “Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS): impact of the inter-stages course on morbi-mortality and implications for management,” European Journal of Surgical Oncology, vol. 41, no. 5, pp. 674–682, 2015. View at Publisher · View at Google Scholar
  12. E. Schadde, V. Ardiles, K. Slankamenac et al., “ALPPS offers a better chance of complete resection in patients with primarily unresectable liver tumors compared with conventional-staged hepatectomies: results of a multicenter analysis,” World Journal of Surgery, vol. 38, no. 6, pp. 1510–1519, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Pandanaboyana, R. Bell, E. Hidalgo et al., “A systematic review and meta-analysis of portal vein ligation versus portal vein embolization for elective liver resection,” Surgery, vol. 157, no. 4, pp. 690–698, 2015. View at Publisher · View at Google Scholar
  14. M. Nagino, J. Kamiya, H. Nishio, T. Ebata, T. Arai, and Y. Nimura, “Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: Surgical outcome and long-term follow-up,” Annals of Surgery, vol. 243, no. 3, pp. 364–372, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Nadalin, I. Capobianco, J. Li, P. Girotti, I. Königsrainer, and A. Königsrainer, “Indications and limits for associating liver partition and portal vein ligation for staged hepatectomy (ALPPS). Lessons learned from 15 cases at a single centre,” Zeitschrift für Gastroenterologie, vol. 52, no. 1, pp. 35–42, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Malinowski, D. Geisel, V. Stary et al., “Portal vein embolization with plug/coils improves hepatectomy outcome,” Journal of Surgical Research, vol. 194, no. 1, pp. 202–211, 2015. View at Publisher · View at Google Scholar
  17. J. Li, P. Girotti, I. Königsrainer, R. Ladurner, A. Königsrainer, and S. Nadalin, “ALPPS in right trisectionectomy: a safe procedure to avoid postoperative liver failure?” Journal of Gastrointestinal Surgery, vol. 17, no. 5, pp. 956–961, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. E. Schadde, V. Ardiles, R. Robles-Campos et al., “Early survival and safety of ALPPS: first report of the International ALPPS Registry,” Annals of Surgery, vol. 260, no. 5, pp. 829–838, 2014. View at Publisher · View at Google Scholar
  19. S. B. Fisher, S. H. Patel, D. A. Kooby et al., “Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis,” HPB, vol. 14, no. 8, pp. 514–522, 2012. View at Publisher · View at Google Scholar · View at Scopus
  20. M. D. Sur, H. In, S. M. Sharpe et al., “Defining the benefit of adjuvant therapy following resection for intrahepatic cholangiocarcinoma,” Annals of Surgical Oncology, vol. 22, no. 7, pp. 2209–2217, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. K. J. Oldhafer, M. Donati, R. M. Jenner, A. Stang, and G. A. Stavrou, “ALPPS for patients with colorectal liver metastases: effective liver hypertrophy, but early tumor recurrence,” World Journal of Surgery, vol. 38, no. 6, pp. 1504–1509, 2014. View at Publisher · View at Google Scholar · View at Scopus